[go: up one dir, main page]

GB0002402D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0002402D0
GB0002402D0 GBGB0002402.6A GB0002402A GB0002402D0 GB 0002402 D0 GB0002402 D0 GB 0002402D0 GB 0002402 A GB0002402 A GB 0002402A GB 0002402 D0 GB0002402 D0 GB 0002402D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0002402.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB0002402.6A priority Critical patent/GB0002402D0/en
Publication of GB0002402D0 publication Critical patent/GB0002402D0/en
Priority to PCT/GB2001/000372 priority patent/WO2001057077A1/en
Priority to AU2001228693A priority patent/AU2001228693A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
GBGB0002402.6A 2000-02-02 2000-02-02 Novel compounds Ceased GB0002402D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0002402.6A GB0002402D0 (en) 2000-02-02 2000-02-02 Novel compounds
PCT/GB2001/000372 WO2001057077A1 (en) 2000-02-02 2001-01-30 Proteins that are specifically expressed or highly overexpressed in tumors and nucleic acids encoding them
AU2001228693A AU2001228693A1 (en) 2000-02-02 2001-01-30 Proteins that are specifically expressed or highly overexpressed in tumors and nucleic acids encoding them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0002402.6A GB0002402D0 (en) 2000-02-02 2000-02-02 Novel compounds

Publications (1)

Publication Number Publication Date
GB0002402D0 true GB0002402D0 (en) 2000-03-22

Family

ID=9884837

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0002402.6A Ceased GB0002402D0 (en) 2000-02-02 2000-02-02 Novel compounds

Country Status (3)

Country Link
AU (1) AU2001228693A1 (en)
GB (1) GB0002402D0 (en)
WO (1) WO2001057077A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0223893D0 (en) * 2002-10-14 2002-11-20 Univ Dundee Kinase modulation assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0972029A1 (en) * 1997-03-07 2000-01-19 Human Genome Sciences, Inc. Human secreted proteins
WO1999016870A1 (en) * 1997-09-29 1999-04-08 Zymogenetics, Inc. Secreted protein zsig-11
CA2327551A1 (en) * 1998-04-24 1999-11-04 Alphagene, Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
WO2001057077A1 (en) 2001-08-09
AU2001228693A1 (en) 2001-08-14

Similar Documents

Publication Publication Date Title
EP1276755A4 (en) Novel compounds
EP1317538A4 (en) Novel compounds
GB0003019D0 (en) Novel compounds
EP1255771A4 (en) Novel compounds
GB0008464D0 (en) Novel compounds
EP1292617A4 (en) Novel compounds
EP1472352A4 (en) Novel compounds
EP1343813A4 (en) Novel compounds
EP1276866A4 (en) Novel compounds
GB0004149D0 (en) Novel compounds
GB0001898D0 (en) Novel compounds
GB0003636D0 (en) Novel compounds
GB0002402D0 (en) Novel compounds
GB0004196D0 (en) Novel compounds
EG22332A (en) Novel compounds
GB0004186D0 (en) Novel Compounds
GB0002330D0 (en) Novel compounds
GB0006132D0 (en) Novel compounds
GB0004917D0 (en) Novel compounds
GB0004414D0 (en) Novel compounds
GB0004269D0 (en) Novel compounds
GB0006560D0 (en) Novel compounds
GB0004188D0 (en) Novel Compounds
GB0005256D0 (en) Novel compounds
GB0006577D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)